Multiple myeloma is the
third-most common blood cancer worldwide, and while incidence is increasing, new treatments are here and on the horizon. But we can do more, especially to help patients in their daily lives. This is the goal of Target the Future: to get ahead of multiple myeloma, together.

Rising to the challenge of multiple myeloma

The multiple myeloma community faces issues that touch many aspects of life, which is why GSK has consulted with patients and caregivers on key challenges including:

• Understanding the options at every step: While more treatments are available, understanding the appropriate options at each step of the journey can be difficult.
• Getting to the right care: Finding or traveling to the right healthcare provider can be hard for patients with limited transportation or location options.
• Relieving the emotional burden: Managing stress associated with diagnosis, treatment, relapse or the overall disruption to one's life can be taxing for both patients and their caregivers.
• Addressing disparities and inequities in care: We need new ideas to help ensure equal access to care and resources.